UL Solutions ULS FX & Other Adjustments

FX & Other Adjustments at other companies

Charles River LaboratoriesCRL

-$18.55M-160%

TranscatTRNS

——

Industrial-$3M-200%

Consumer-$2M-167%

Risk & Compliance Software$0—

Revenue$758.0M+7.5%

Gross profit$381.0M+12.1%

Operating income$138.0M+26.6%

Net income$92.0M+37.3%

EPS (diluted)$0.45+36.4%

Cash & equivalents$258.0M-3.4%

Total debt$539.0M-36.1%

Total equity$1.3B+36.0%

Total assets$3.0B+2.7%

Operating cash flow$219.0M+42.2%

CapEx$69.0M+35.3%

Free cash flow$150.0M+45.6%

Market cap$20.53B+35.1%

Enterprise value$20.81B+32.2%

P/E58.7×+12.2×

P/S6.6×+1.5×

Gross margin49.9%+1.3pp

Operating margin17.7%+1.2pp

Net margin11.3%-0.3pp

FCF margin14.5%+4.0pp

Return on equity30.6%-10.5pp

Debt / equity0.4×-0.5×

Current ratio1.2×-0.1×